Mesnex Oral Tablet 400Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Mesnex: Oral tablet (400mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Mesnex 400mg Tab

What is this Medicine?

MESNA (MES na) is used to prevent bleeding from the bladder during treatment with ifosfamide. This medicine does not reduce the chance of getting other side effects of cancer chemotherapy.

CVS Pharmacy Patient Statistics for Mesnex: Oral tablet(400mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Mesnex 400mg Tablet

NDC: 671083565
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Hemorrhagic Cystitis

Storage Information
Store at controlled room temperature (between 68 and 77 degrees F)
Mesnex 400mg Tablet

Reported Side Effects for Mesnex 400mg Tablet

Flushing Incidence:
0.8-5.0%*
Severity: MILD
Onset: RAPID
Rapid Heart Rate Incidence:
0.8-5.9%*
Severity: MODERATE
Onset: RAPID
Excessive Sweating Incidence:
1.7-7.6%*
Severity: MILD
Onset: DELAYED
Dehydration Incidence:
2.5-5.9%*
Severity: MODERATE
Onset: DELAYED
Low Blood Pressure Incidence:
3.4-5.0%*
Severity: MODERATE
Onset: RAPID
Nervousness Incidence:
3.4-5.9%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
3.4-5.0%*
Severity: MILD
Onset: EARLY
Pale Skin Incidence:
3.4-5.0%*
Severity: MILD
Onset: EARLY
Cough Incidence:
4.2-8.4%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
4.2-7.6%*
Severity: MILD
Onset: EARLY
Back Pain Incidence:
5.0-6.7%*
Severity: MILD
Onset: DELAYED
Inability To Sleep Incidence:
5.0-9.2%*
Severity: MILD
Onset: EARLY
Confusion Incidence:
5.0-5.9%*
Severity: MODERATE
Onset: EARLY
Blood In The Urine Incidence:
5.9-6.7%*
Severity: MODERATE
Onset: DELAYED
Fluid Retention Incidence:
6.7%*
Severity: MODERATE
Onset: DELAYED
Drowsiness Incidence:
6.7-10.1%*
Severity: MILD
Onset: EARLY
Swelling Incidence:
6.7-7.6%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
7.6-14.3%*
Severity: MILD
Onset: EARLY
Headache Incidence:
7.6-10.9%*
Severity: MILD
Onset: EARLY
Low Potassium Levels Incidence:
8.4-9.2%*
Severity: MODERATE
Onset: DELAYED
Chest Pain Incidence:
8.4-9.2%*
Severity: MODERATE
Onset: EARLY
Shortness Of Breath Incidence:
9.2%*
Severity: MODERATE
Onset: EARLY
Hair Loss Incidence:
10.1-10.9%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
11.8-15.1%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
12.6-17.6%*
Severity: MILD
Onset: DELAYED
Low Platelet Count Incidence:
13.4-17.6%*
Severity: MODERATE
Onset: DELAYED
Fever Incidence:
15.1-20.2%*
Severity: MILD
Onset: EARLY
Decreased Appetite Incidence:
16.0-17.6%*
Severity: MILD
Onset: DELAYED
Anemia Incidence:
16.8-17.6%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
17.6-21.0%*
Severity: MODERATE
Onset: DELAYED
Constipation Incidence:
17.6-23.5%*
Severity: MODERATE
Onset: DELAYED
Tired Incidence:
20.2%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
29.4-37.8%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
53.8-54.6%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
First Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Second Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Third Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Mesnex

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5